Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
Welcome to the calm before the Covid-19 storm.
The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.
Medtronic has lined up a whole pipeline of new devices – and it will need them.
The good times continue to roll for big cap device makers, with two companies doubling their market value, and not a single share price fall.
The market for minimally invasive aortic implants is sewn up – can a tiny private group find a way in?